Drug legalization -- California : Reducing drug trafficking revenues and violence in Mexico : would legalizing marijuana in California help? / Beau Kilmer [and others]
Drug legalization -- Mexico : Proyecto no. 945 / Open City Works ; producción, Paula Vilella, Rodrigo Muñoz Nava y Arturo Pérez Torres ; dirección, Arturo Pérez Torres
Drug legalization -- Research -- Case studies. : In-depth interviews and virtual forums : mix of methods for decriminalization of drug consumption in Latin America / Victoria Sánchez Antelo
Drug legalization -- Vermont : Considering marijuana legalization : insights for Vermont and other jurisdictions / Jonathan P. Caulkins, Beau Kilmer, Mark A.R. Kleiman, Robert J. MacCoun, Gregory Midgette, Pat Oglesby, Rosalie Liccardo Pacula, Peter H. Reuter
The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed)
Reduction of pharmacologic activity or toxicity of a drug or other foreign substance by a living system, usually by enzymatic action. It includes those metabolic transformations that make the substance more soluble for faster renal excretion
Reduction of pharmacologic activity or toxicity of a drug or other foreign substance by a living system, usually by enzymatic action. It includes those metabolic transformations that make the substance more soluble for faster renal excretion
The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include pharmacokinetics, dosage analysis, or drug administration analysis
The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include pharmacokinetics, dosage analysis, or drug administration analysis
Drug monitoring -- Congresses : Adverse drug event reporting : the roles of consumers and health-care professionals : workshop summary / Jeffrey M. Drazen [and others], rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy ; Institute of Medicine of the National Academies
Drug Monitoring -- standards : Emerging safety science : workshop summary / Sally Robinson, Robert Pool, and Robert Giffin [rapporteurs] ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies
Drug monitoring -- United States -- Congresses : Building a national capability to monitor and assess medical countermeasure use during a public health emergency : going beyond the last mile: proceedings of a workshop / Morgan Boname, Theresa Wizemann, and Justin Snair, rapporteurs ; Board on Health and Science Policy, Health and Medicine Division, the National Academies of Sciences, Engineering, Medicine
Drug-nutrient interactions -- Catalogs. : Natural medicines comprehensive database / complied by the editors of, Pharmacist's Letter, Prescriber's Letter ; [editor, Jeff M. Jellin]
